Comparison
46 Xx Disorder Of Sex Development Induced By Endogenous Maternal Derived Androgen C5679875 vs 3m Syndrome 3 C3280146
Clinical comparison between 46 XX Disorder OF Sex Development Induced BY Endogenous Maternal Derived Androgen and 3M Syndrome 3 for differential diagnosis and treatment planning.
46 Xx Disorder Of Sex Development Induced By Endogenous Maternal Derived Androgen C5679875
A condition where hormones from the mother cross the placenta and cause atypical development in an XX fetus. It is present at birth. Management involves pediatric specialists and may include hormone therapy.
3m Syndrome 3 C3280146
A genetic condition causing intrauterine growth restriction and postnatal short stature with distinctive facial features. Treatment focuses on growth monitoring and supportive measures.
6 comparison axes
Onset
46 Xx Disorder Of Sex Development Induced By Endogenous Maternal Derived Androgen C5679875
Variable
3m Syndrome 3 C3280146
0-0
Onset patterns differ
Severity
46 Xx Disorder Of Sex Development Induced By Endogenous Maternal Derived Androgen C5679875
severe
3m Syndrome 3 C3280146
moderate
Different severity levels
Chronic
46 Xx Disorder Of Sex Development Induced By Endogenous Maternal Derived Androgen C5679875
Chronic
3m Syndrome 3 C3280146
Chronic
Differing course
Communicable
46 Xx Disorder Of Sex Development Induced By Endogenous Maternal Derived Androgen C5679875
No
3m Syndrome 3 C3280146
No
Different transmission
Body System
46 Xx Disorder Of Sex Development Induced By Endogenous Maternal Derived Androgen C5679875
reproductive
3m Syndrome 3 C3280146
musculoskeletal
Same/different system
Category
46 Xx Disorder Of Sex Development Induced By Endogenous Maternal Derived Androgen C5679875
endocrine
3m Syndrome 3 C3280146
genetic
Different category
Bottom line
46-xx-disorder-of-sex-development-induced-by-endogenous-maternal-derived-androgen-C5679875 and 3m-syndrome-3-C3280146 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 46 Xx Disorder Of Sex Development Induced By Endogenous Maternal Derived Androgen C5679875 | 3m Syndrome 3 C3280146 | Discriminating power |
|---|---|---|---|
| Genital development | Atypical sex development in an XX newborn may be present. | A primary genital disorder is not described. | High |
| Growth pattern | Intrauterine growth restriction is not the defining feature. | Intrauterine restriction and postnatal short stature are central. | High |
| Facial appearance | Distinctive facial features are not established by the source. | Distinctive facial features are described, without specific traits supplied. | Moderate |
When to favor each condition
Choose 46 Xx Disorder Of Sex Development Induced By Endogenous Maternal Derived Androgen C5679875 when
XX newborn with atypical genital development
The source centers on prenatal maternal androgen exposure.
High
Suspected maternal androgen source
Endocrine and pregnancy history are more relevant than growth syndrome features.
Moderate
Need for DSD specialist planning
Pediatric endocrine and multidisciplinary care may be appropriate.
Moderate
Choose 3m Syndrome 3 C3280146 when
Growth restriction before and after birth
This pattern is the stated core of 3M syndrome 3.
High
Short stature with distinctive facies
The combination points toward the genetic growth condition.
Moderate
No primary disorder of sex development
Musculoskeletal and genetic features predominate in the source.
Moderate
How key tests differ
| Test | 46 Xx Disorder Of Sex Development Induced By Endogenous Maternal Derived Androgen C5679875 | 3m Syndrome 3 C3280146 | Interpretation |
|---|---|---|---|
| Karyotype or sex-chromosome study | 46,XX is part of the named condition. | No specific chromosomal result is supplied. | A karyotype supports classification but does not alone prove the cause. |
| Endocrine and maternal-androgen evaluation | Findings may support excess prenatal androgen exposure. | Androgen excess is not the described mechanism. | Abnormal hormone results need clinician interpretation and are not a complete diagnosis. |
| Growth assessment and genetic testing | Not primarily used to establish this condition. | May support a genetic short-stature syndrome. | A specific causative result is not provided here and requires specialist review. |
Prognosis comparison
46 Xx Disorder Of Sex Development Induced By Endogenous Maternal Derived Androgen C5679875
- Outcome
- A chronic condition whose long-term outcome is not quantified here.
- Factors
- Degree of atypical development, endocrine findings, and timing of specialist care.
3m Syndrome 3 C3280146
- Outcome
- Chronic short stature with supportive management; exact prognosis is not supplied.
- Factors
- Growth pattern, associated features, and genetic confirmation.
Time frame: Both may be evident from fetal life or birth and continue long term.
Etiology, severity, associated findings, and access to appropriate care.
Complications comparison
| Complication | Presentation |
|---|---|
| Development-related concerns | Atypical genital development may need specialist follow-up. Persistent short stature is the main described concern. Complication rates are not established by the source. |
| Associated physical features | Additional anomalies are not specified here. Distinctive facial features may accompany growth restriction. Features should be assessed individually rather than assumed. |
| Long-term care needs | Hormone therapy may be considered, but no dose is established. Growth monitoring and supportive care are emphasized. Treatment decisions require pediatric specialist judgment. |
Patient education highlights
- HighDifferent conditions
One concerns prenatal androgen effects on an XX fetus; the other concerns genetic growth and facial features.
- HighSpecialist care
Diagnosis and management should be guided by pediatric specialists; do not rely on a single test.
- MediumTransmission
Neither condition is described as communicable. Inheritance details for 3M syndrome 3 need genetic counseling.